close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Guardant Health, Inc.

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to Participate in Upcoming Investor Conferences
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
From Guardant Health, Inc.
Via Business Wire
Tickers GH HKMPY OTC
News headline image
Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health Announces Tentative Date of FDA Advisory Panel Review of Shield™ Blood Test
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to Appeal Federal District Court Verdict
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to Participate in Upcoming November Investor Conferences
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health, Flatiron Health Announce Integration of Guardant Genomic Profiling Tests Into OncoEMR® Platform
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health Receives Coverage for Guardant Reveal™ from Geisinger Health Plan
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to Host Investor Day on September 7, 2023
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health receives first commercial payor coverage for Guardant Reveal™ test from Blue Cross and Blue Shield of Louisiana
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to Report Second Quarter 2023 Financial Results on August 3, 2023
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan
From Guardant Health, Inc.
Via Business Wire
Tickers GH
News headline image
Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting
From Guardant Health, Inc.
Via Business Wire
Tickers GH
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today